About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2018 ASCO Annual Meeting
AACR Annual Meeting 2018
The Policy, Politics & Law of Cancer
Methotrexate–Induced Kidney Injury
NCCN 22nd Annual Conference
Today In Oncology
FDA Clears Expanded Indication of Scalp-Cooling System
AMA Rejects Recommendation to Reaffirm Opposition to Medical Aid in Dying
Male Thyroid Cancer Survivors Face 50% Higher Risk of Cardiovascular Disease Than Women
Prophylactic Cranial Irradiation in Stage III NSCLC
Low-Fat Dietary Intervention and Overall Survival After Breast Cancer Diagnosis
Most Read Stories
‘Pearls of Wisdom’ for Leadership and Success in Academic Medicine Gathered Over a 35-Year Career
ASCO 2015: Nivolumab Extends Survival for Patients With Nonsquamous Non–Small Cell Lung Cancer
Abiraterone or Docetaxel: Which Is Optimal for Hormone-Sensitive High-Risk Prostate Cancer?
2018 ASCO: KEYNOTE-042 Trial Compares Pembrolizumab With Chemotherapy as First-Line Treatment of NSCLC With PD-L1 Expression of 1% or More
Weighing the Cost and Value of CAR T-Cell Therapy
© 2018 HSP News Service, L.L.C.
to learn more.